Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

2(67%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 3Large-scale testing

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Detailed Status

Recruiting2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (50.0%)

N/A1 (50.0%)

Trials by Status

recruiting267%

completed133%

Recent Activity

2 active trials

Showing 3 of 3

recruitingphase_3

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

NCT05908084

recruitingnot_applicable

Comparison of Three Types of Distal Arteriovenous Fistulas: SBAVF, RCAVF, and RCAVF With Venous Branch Patch.

NCT06550479

completed

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula

NCT06199609

Clinical Trials (3)

Showing 3 of 3 trials

NCT05908084Phase 3

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

Recruiting

NCT06550479Not Applicable

Comparison of Three Types of Distal Arteriovenous Fistulas: SBAVF, RCAVF, and RCAVF With Venous Branch Patch.

Recruiting

NCT06199609

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula

Completed

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3